Nordwand Advisors’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-258,000
Closed -$6.76K 132
2023
Q1
$6.76K Buy
258,000
+8,000
+3% +$222 ﹤0.01% 105
2022
Q4
$1.35K Buy
+250,000
New +$11.3K ﹤0.01% 67

Other funds holding ATIP.WS

Nordwand Advisors's ATIP.WS Position: Q2 2023 in Review

Nordwand Advisors sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q2 2023, closing a stake of 258,000 shares — an estimated $6.76K sold.

Nordwand Advisors first reported a position in ATIP.WS in Q4 2022 and held it in 2 quarters. The position peaked at $6.76K in Q1 2023. 1 fund tracked by Wall St. Rank holds ATIP.WS as of Q2 2023.

  • Nordwand Advisors reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
  • Nordwand Advisors sold 258,000 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2023, an estimated $6.76K.
  • Nordwand Advisors first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q4 2022 and held it in 2 quarters.
  • Nordwand Advisors's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $6.76K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2023.

Based on Nordwand Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.